Detalhe da pesquisa
1.
Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina.
Neurol Sci
; 45(2): 379-389, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38159147
2.
Performance of McDonald 2017 multiple sclerosis diagnostic criteria and evaluation of genetic ancestry in patients with a first demyelinating event in Argentina.
Mult Scler
; 29(4-5): 559-567, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36942953
3.
Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting.
Mult Scler
; 29(10): 1240-1249, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37491849
4.
Radiologically isolated syndrome: from biological bases to practical management.
Neurol Sci
; 42(4): 1335-1344, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33496891
5.
Adaptation and validation of a Spanish version of the treatment burden questionnaire in patients with multiple sclerosis.
BMC Neurol
; 19(1): 209, 2019 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31455235
6.
The Lancet Commission on the future of care and clinical research in autism.
Lancet
; 399(10321): 271-334, 2022 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34883054
7.
Multiple Sclerosis and Aging: The Dynamics of Demyelination and Remyelination.
ASN Neuro
; 14: 17590914221118502, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35938615
8.
The central vein sign is present in most infratentorial multiple sclerosis plaques.
Mult Scler Relat Disord
; 58: 103484, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35007822
9.
Rebound activity after fingolimod cessation: A case - control study.
Mult Scler Relat Disord
; 57: 103329, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158443
10.
Real-world effectiveness of natalizumab treatment in patients with relapsing multiple sclerosis in Argentina and Chile.
Arq Neuropsiquiatr
; 79(5): 407-414, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161529
11.
Immunomodulatory effects of Vitamin D in multiple sclerosis.
Brain
; 132(Pt 5): 1146-60, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19321461
12.
Consensus recommendations on the management of multiple sclerosis patients in Argentina.
J Neurol Sci
; 409: 116609, 2020 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31816524
13.
Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis.
Biomedicines
; 7(1)2019 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30791637
14.
Argentinean recommendations on the identification of treatment failure in relapsing remitting multiple sclerosis patients.
J Neurol Sci
; 385: 217-224, 2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29406907
15.
Real-world effectiveness of natalizumab treatment in patients with relapsing multiple sclerosis in Argentina and Chile / Efectividad en el mundo real del tratamiento con Natalizumab para pacientes con esclerosis múltiple recurrente en Argentina y Chile
Arq. neuropsiquiatr
; 79(5): 407-414, May 2021. tab, graf
Artigo
em Inglês
| LILACS | ID: biblio-1278402
16.
Role of prolactin in B cell regulation in multiple sclerosis.
J Neuroimmunol
; 269(1-2): 76-86, 2014 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24612525
17.
Corrigendum to "Argentinean recommendations on the identification of treatment failure in relapsing remitting multiple sclerosis patients" [J. Neurol. Sci. 385C (2018) 217-224].
J Neurol Sci
; 387: 231-232, 2018 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29449007
18.
Neutropenia in Patients With Multiple Sclerosis Treated With Alemtuzumab.
JAMA Neurol
; 74(9): 1143-1144, 2017 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28715536
19.
Vitamin D-mediated immune regulation in multiple sclerosis.
J Neurol Sci
; 311(1-2): 23-31, 2011 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21723567